1. Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate‐to‐severe facial erythema associated with rosacea. (16th July 2014) Authors: Benkali, K.; Leoni, M.; Rony, F.; Bouer, R.; Fernando, A.; Graeber, M.; Wagner, N. Journal: British journal of dermatology Issue: Volume 171:Number 1(2014:Jul.) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative pharmacokinetics and bioavailability of brimonidine following ocular and dermal administration of brimonidine tartrate ophthalmic solution and gel in patients with moderate‐to‐severe facial erythema associated with rosacea. (1st July 2014) Authors: Benkali, K.; Leoni, M.; Rony, F.; Bouer, R.; Fernando, A.; Graeber, M.; Wagner, N. Journal: British journal of dermatology Issue: Volume 171:Number 1(2014:Jul.) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR‐γ selective topical retinoid, in patients with moderate facial and truncal acne. (20th August 2019) Authors: Blume‐Peytavi, U.; Fowler, J.; Kemény, L.; Draelos, Z.; Cook‐Bolden, F.; Dirschka, T.; Eichenfield, L.; Graeber, M.; Ahmad, F.; Alió Saenz, A.; Rich, P.; Tanghetti, E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 1(2020) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗